About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

BioWare for AUD and PTSD | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05187364

BioWare for AUD and PTSD

This study examines the ability of an innovative telehealth technology system to enhance Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) talk-therapy for indiv...

Lead sponsor: Medical University of South Carolina•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Medical University of South Carolina

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Male or female; aged 18-70 years.
•2. Able to provide written informed consent.
•3. Meet DSM-5 diagnostic criteria for current moderate to severe alcohol use disorder.
•4. Meet DSM-5 diagnostic criteria for current PTSD.
•5. Participants taking psychotropic medications will be required to be maintained on a stable dose for at least 4 weeks before study initiation.

Exclusion Criteria

•1. Meet DSM-5 criteria for a history of or current psychotic or bipolar disorders.
•2. Current suicidal or homicidal ideation and intent.
•3. Psychotropic medications which have been initiated during the past 4 weeks.
•4. Acute alcohol withdrawal.
•5. Pregnancy or breastfeeding for people of childbearing potential.
•6. Currently enrolled in evidence based behavioral treatment for AUD or PTSD.
•7. Implanted electronic devices of any kind, including pacemakers, electronic infusion pumps, stimulators, defibrillators or similar.

Related studies

RECRUITINGPhase 1

Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

NCT07223983 · Alcohol Use Disorder, Weight Loss, and more

RECRUITINGPhase 1

Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder

NCT07506395 · PTSD

RECRUITINGPhase 1

Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)

NCT07027839 · Alcohol Use Disorder

Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study

NCT06770556 · Alcohol Use Disorder, Alcohol Dependence, and more

Multi-component Family Intervention to Lower Depression and Address Intimate Partner Violence in Nepal

NCT06834867 · Intimate Partner Violence (IPV), Depression, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 24, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment4

Start dateMay 2022

Last updatedSep 24, 2024

Condition

PTSD Alcohol Use Disorder

Locations shown

Medical University of South Carolina

Charleston, South Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 24, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions